Lawrence Serfaty

8PUBLICATIONS
40CO-AUTHORS
Predictive and prognostic markersNutritional epidemiologyEnglish languageOther education not elsewhere classifiedNutrigenomics and personalised nutrition
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Dec 17, 2025
RIPK1 inhibition reduces biliary injury and fibrosis in primary sclerosing cholangitis.

Pierre-Antoine Soret, Virginie Steunou, Julien Hedou

|Jul 15, 2023
The NAFLD burden on mortality and morbidities in general population: A community-based longitudinal study (NASH-CO study).

Oumarou Nabi, Nathanaël Lapidus, Jerome Boursier

|Feb 23, 2023
Lean individuals with NAFLD have more severe liver disease and poorer clinical outcomes (NASH-CO Study).

Oumarou Nabi, Nathanaël Lapidus, Jerome Boursier

|Jul 05, 2022
Reply.

Coralie Amadou, Oumarou Nabi, Lawrence Serfaty

|Apr 27, 2022
Association between birth weight, preterm birth, and nonalcoholic fatty liver disease in a community-based cohort.

Coralie Amadou, Oumarou Nabi, Lawrence Serfaty

|Jan 23, 2022
The burden of NAFLD in type 2 diabetic subjects from the general population: A Nationwide population-based follow-up study (NASHCO).

Oumarou Nabi, Jerome Boursier, Nathanaël Lapidus

Pageof 2